Proacta S.A.
1.57
PLN
-0.01
(-0.63%)
ISIN
PLBTEVL00019
Return %
Stock
S&P 500
1Y
35.34
14.20
3Y
47.18
81.12
5Y
-23.94
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Pawel Ciesielka
- Full Time Employees
- 15
- Sector
- Technology services
- Industry
- Information technology services
- Address
- Warsaw Poland
- Website
- proacta.pl
- Similar Companies
- Business
- Proacta S.A. is a Poland-based technology and bioinformatics company that designs, develops, and delivers artificial intelligence-powered healthcare software solutions and enterprise information technology services. The company operates primarily across two business segments: Medical Technology and Bioinformatics, and Enterprise IT and Software Engineering Services. Under its Medical Technology and Bioinformatics segment, the company develops proprietary clinical and health data platforms, including Dbam o Siebie Smart LAB, a digital system that analyzes laboratory test results to generate automated, personalized diagnostic interpretations and health recommendations; Digital Breast Cancer Unit (DBCU), an intelligent clinical platform that assists multidisciplinary medical teams in oncological diagnosis, treatment path optimization, and patient monitoring; DataBION, a proprietary biomedical data analytics and aggregation engine designed for clinical research and predictive health modeling; and specialized patient portals facilitating secure medical record access and preventative care management. Under its Enterprise IT and Software Engineering segment, Proacta S.A. provides end-to-end bespoke software development for web and mobile platforms; artificial intelligence and machine learning engineering, including predictive data analytics and medical text processing; cloud architecture design and DevOps engineering; cybersecurity and IT infrastructure integration; and long-term application maintenance, legacy modernization, and IT consulting services. The company caters to healthcare institutions, oncology centers, research organizations, public sector agencies, and commercial enterprises primarily across Poland and the European Union. In recent developments, the company executed a major strategic shift and corporate rebranding to Proacta S.A. (formerly known as Codeaddict S.A. and Bit Evil S.A.) following the acquisition and operational integration of Proacta sp. z o.o., pivoting its primary strategic focus toward medical artificial intelligence, oncology diagnostics, and bioinformatics. The company has advanced the commercial rollout of its proprietary healthcare solutions, notably achieving commercial clinical deployment of its Digital Breast Cancer Unit system at the Opole Oncology Center. Additionally, Proacta S.A. entered into a strategic collaboration with Integrated Solutions, an Orange Group company, to co-develop artificial intelligence decision-support tools for healthcare professionals, while securing multi-year public sector enterprise IT implementation contracts. To guide its ongoing research and development initiatives in predictive medicine and longevity technologies, the company also established a dedicated Medical Advisory Board. Proacta S.A. was founded in 2015 and is headquartered in Warsaw, Poland, with an additional branch office in Lublin, Poland.